GNH India, one of India’s top global pharmaceutical distributor, has recently cleared the audit by Pharmacy and Poisons Board of Kenya, and has become first Indian pharmaceutical wholesaler to clear an audit by a foreign government body.
The certification will help GNH India trade freely with Kenya. The company will export the first shipment of lifesaving drugs to Kenya shortly and is looking to establish long lasting business relations with the country. The country, which has been facing a dearth of many lifesaving drugs in recent times will be benefited by this development.
“We always adhere to appropriate practices and maintain quality standards while servicing our clients, and being certified by the Pharmacy and Poisons Board, Kenya authenticates the measures taken by us for the exports of medicines. It gives us tremendous pleasure to be the first Indian specialised wholesaler to clear the audit by any foreign body, and we look forward to many more opportunities,” said Dr Piyush Gupta, Associate Director, GNH India.
GNH India exports to more than 180 countries and has 135,000 product lines to choose from which makes this company one of the leading businesses in the $12.5 billion Indian pharmaceutical export industry.
This recent development has extended their reach into Kenya which has added to the long list of countries they already export medicines to. GNH India had recently also exported a large consignment of life saving dugs (LSD) to Yemen among other countries in Africa and the Middle East.
GNH India was audited in compliance to Good Distribution Practices (GDP), the criteria of the audit are based on World Health Organisation’s (WHO) Good Distribution Practices for Pharmaceutical products and European Union’s guidelines on GDP of medical products for human use.